| 18 years and more
- | Country :
- France
- | organs :
- Leucémies chroniques
- | Specialty :
- Chimiothérapie
Extract
An open-label, multi-center, three arm randomized study to investigate the safety and efficacy on progression-free survival of RO5072759 + chlorambucil (GClb) compared to rituximab + chlorambucil (RClb) or chlorambucil (Clb) alone in previously untreated CLL patients with comorbidities.
Scientific Abstract
en cours d'intégration;